**Acknowledgements**

We would like to thank Medicines for Malaria Venture and the National Institutes of Health for supporting our efforts in developing 4(1H)-quinolones with antimalarial activity. In particular, we are grateful for MMV awards 08/0068, 11/0022 and 16/00421 and NIH awards GM097118 and AI144464.
